Melanoma Focus
Financial health, per its FY2025 accounts
The accounts state that the charity reported a net deficit of £35,313 for the year ended 31 January 2025, resulting in total funds decreasing to £298,740. Per the trustees' report, unrestricted free reserves stood at £270,361, which is above the stated desired level of £200,000. The trustees confirmed adequate resources for going concern and noted that the charity qualifies as small under the Companies Act 2006.
What the accounts disclose
“The remuneration of the CEO was £70,752 in the year, including employer's costs (2024: £70,280).”
“The number of employees whose employee benefits (excluding employer pension costs) exceeded £60,000 was: 2025 No. In the band £60,001 - £70,000 -” — page 26
“The Trustees aim to maintain free reserves in unrestricted funds at a desired level of £200,000, with a minimum necessary of £180,000.” — page 7
Corporate structure
- Registered company of the charity Companies House 06057181
Structured financials (annual return, FY ending 31/01/2025)
Register events
- Received assets from another charity (13/09/2024)
- Received assets from another charity (31/01/2014)
Trustees
- Dr Mark Harrieschair
- ALAN HOWARD SKYRME PEACH
- CAROLINE DENISE STEVENS
- Carl Horrobin
- Dr Miranda Payne
- George Oliver Ulmann
- Hugh William Munro
- Imogen Cheese
- Jacqueline Anne Hodgetts
- Kayley Anne Dempsey
- Professor Catherine Anne Harwood
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/01/2025 | £502k | £538k |
| 31/01/2024 | £546k | £499k |
| 31/01/2023 | £352k | £355k |
| 31/01/2022 | £386k | £352k |
| 31/01/2021 | £263k | £245k |
Common questions
Is Melanoma Focus financially healthy?
The accounts state that the charity reported a net deficit of £35,313 for the year ended 31 January 2025, resulting in total funds decreasing to £298,740. Per the trustees' report, unrestricted free reserves stood at £270,361, which is above the stated desired level of £200,000. The trustees confirmed adequate resources for going concern and noted that the charity qualifies as small under the Companies Act 2006. Its FY2025 accounts were independently examined.
What does the highest-paid employee of Melanoma Focus earn?
Per its FY2025 accounts, the highest-paid employee was in the £60,001 - £70,000 band, and 1 employees earned over £60,000.
Who funds Melanoma Focus?
Funders whose own accounts filings name Melanoma Focus as a grant recipient include THE ORR MACKINTOSH FOUNDATION LIMITED, THE SHERLING CHARITABLE TRUST, THE SANDHU CHARITABLE FOUNDATION, BNA CHARITABLE INCORPORATED ORGANISATION, MAY HEARNSHAW CHARITABLE TRUST.
Known funders
| Funder | Year | Amount |
|---|---|---|
| THE ORR MACKINTOSH FOUNDATION LIMITED | FY2025 | £20k |
| THE SHERLING CHARITABLE TRUST | FY2026 | £5k |
| THE SANDHU CHARITABLE FOUNDATION | FY2025 | £5k |
| BNA CHARITABLE INCORPORATED ORGANISATION | FY2024 | £5k |
| MAY HEARNSHAW CHARITABLE TRUST | FY2023 | £5k |
| SHEFFIELD TOWN TRUST | FY2025 | £5k |
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| THE MAURICE WOHL CHARITABLE FOUNDATION | 1 | £400k |
| THE CHARLES WOLFSON CHARITABLE TRUST | 1 | £150k |
| Blood Cancer UK Research | 1 | £87k |
| THE REGATTA FOUNDATION | 1 | £50k |
| THE UKI CHARITABLE FOUNDATION | 1 | £38k |
| THE ERANDA ROTHSCHILD FOUNDATION | 1 | £20k |
| RECHOV GORDON CHARITABLE TRUST | 1 | £5k |